We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$610B
AUM Growth
-$181B
Cap. Flow
-$168B
Cap. Flow %
-27.5%
Top 10 Hldgs %
30.63%
Holding
3,114
New
154
Increased
1,364
Reduced
1,248
Closed
171

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.76B
2
LLY icon
Eli Lilly
LLY
+$1.4B
3
BAC icon
Bank of America
BAC
+$1.3B
4
TSLA icon
Tesla
TSLA
+$1.19B
5
WFC icon
Wells Fargo
WFC
+$784M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.47B
2
AMZN icon
Amazon
AMZN
+$3.71B
3
YUM icon
Yum! Brands
YUM
+$2.84B
4
CRM icon
Salesforce
CRM
+$2.77B
5
FTV icon
Fortive
FTV
+$2.41B

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 18.72%
3 Consumer Discretionary 14.62%
4 Financials 10.36%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPIR icon
2901
Spire Global
SPIR
$550M
$23K ﹤0.01%
2,645
+1,153
+77% +$12.5K
PEAR
2902
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$22K ﹤0.01%
+10,400
New +$17.6K
OTLK icon
2903
Outlook Therapeutics
OTLK
$163M
$21K ﹤0.01%
830
+270
+48% +$6.28K
KALA icon
2904
KALA BIO
KALA
$17.2M
$20K ﹤0.01%
36
+30
+500% +$23.6K
MAPS
2905
DELISTED
WM TECHNOLOGY INC A
MAPS
$20K ﹤0.01%
+12,208
New +$34.7K
ML
2906
DELISTED
MoneyLion Inc.
ML
$20K ﹤0.01%
739
+279
+61% +$12.8K
AOK icon
2907
iShares Core Conservative Allocation ETF
AOK
$795M
$19K ﹤0.01%
+569
New +$19.7K
POL
2908
DELISTED
Polished.com Inc.
POL
$19K ﹤0.01%
718
LPTH icon
2909
Lightpath Technologies
LPTH
$836M
$17K ﹤0.01%
15,300
BINI
2910
DELISTED
Bollinger Innovations
BINI
0
EMAN
2911
DELISTED
eMagin Corporation
EMAN
$17K ﹤0.01%
27,300
SPPI
2912
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$16K ﹤0.01%
35,352
-5,596
-14% -$5.5K
QUMU
2913
DELISTED
Qumu Corp.
QUMU
$16K ﹤0.01%
24,600
-40,350
-62% -$29.3K
BODI icon
2914
The Beachbody Company
BODI
$47M
$15K ﹤0.01%
+296
New +$18.8K
LTCH
2915
DELISTED
Latch, Inc. Common Stock
LTCH
$15K ﹤0.01%
+15,030
New +$17.2K
ATIP
2916
DELISTED
ATI Physical Therapy, Inc.
ATIP
$15K ﹤0.01%
+282
New +$16K
ATER icon
2917
Aterian
ATER
$5.22M
$14K ﹤0.01%
+881
New +$25.6K
EFA icon
2918
iShares MSCI EAFE ETF
EFA
$80.3B
$14K ﹤0.01%
+24
New +$1.5K
RLX icon
2919
RLX Technology
RLX
$2.44B
$14K ﹤0.01%
13,300
-2,200
-14% -$3.37K
ZYNE
2920
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$14K ﹤0.01%
18,200
LYLT
2921
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$14K ﹤0.01%
11,474
-14,380
-56% -$37.3K
HYMC icon
2922
Hycroft Mining Holding Corp
HYMC
$2.46B
$13K ﹤0.01%
2,082
+641
+44% +$5.69K
NGNE icon
2923
Neurogene
NGNE
$727M
$13K ﹤0.01%
1,015
HIND
2924
Vyome Holdings
HIND
$14.9M
-1
Closed -$132K
RKLY
2925
DELISTED
Rockley Photonics Holdings Limited
RKLY
$11K ﹤0.01%
+14,094
New +$24K

Similar funds

T. Rowe Price Associates's Q3 2022 Portfolio in Review

As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.

  • T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
  • T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
  • T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
  • T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
  • T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
  • T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.